Taurolidine treatment for myc-expressing tumors in mammalian bodies
AssigneeCorMedix Inc.
InventorsBruce Reidenberg, Robert DiLuccio
Life of this patent
Estimating the term…
Abstract
A method for treating a cancer which overexpresses any of N-myc genes, C-myc genes and/or L-myc genes in a mammalian body, the method comprising: administering a composition to the mammalian body, wherein the composition comprises at least one from the group consisting of taurolidine; taurultam; taurinamide; methylene glycol; taurultam and taurinamide in a ratio of 1 taurultam:7 taurinamide; and taurultam, taurinamide and methylene glycol in a ratio of 1 taurultam:7 taurinamide:1 methylene glycol.
Claims20
A method for treating a cancer which overexpresses any of N-myc genes, C-myc genes and/or L-myc genes in a mammalian body, the method comprising:
- administering a composition to the mammalian body, wherein the composition comprises
- taurultam and taurinamide in a weight ratio of 1 taurultam:7 taurinamide.
-4. (canceled)
-13. (canceled)
-18. (canceled)
(canceled)
Dependencies are inferred from the claim text.